Content
04/10/2024
Eden Prairie, MN USA
Elucent Medical
completed $42.5 million Series C Round funding. Investors include
Vensana Capital (lead), RC Capital.
About
Elucent Medical sought to solve the unanswered clinical needs of delivering oncologic therapies at the precise location of the disease. Through the revolutionary design of the SmartClipTM soft tissue marker and the EnVisioTM Navigation system, patient care transforms from a point to point indicator to real-time 3D navigation.
This precise location and navigation become especially valuable in treating disease where the anatomy lacks anatomic landmarks.
Elucent Medical delivers solutions that enable surgeons to provide individualized patient care from simple to complex.”
Startup
Sector:
MedTech
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
